Nicholas C.

Co-founder and Advisor

Weston, United States

Experience

Mar 2025 - Present
9 months

Co-founder and Advisor

Tesseract Medicines

Mar 2025 - Jul 2025
5 months

Venture Fellow

Arkitekt Ventures

  • Conduct diligence and market landscaping for healthcare/life science companies.

  • Source early-stage innovation from academic labs, incubators, and emerging biotechs.

Feb 2025 - Present
10 months

Drug Discovery Consultant

Ligo Therapeutics

  • Providing medicinal chemistry and scientific strategy support for AI-driven discovery of covalent small-molecule drugs.
Jun 2024 - May 2025
1 year

Co-founder

Tiago Therapeutics

  • Developed company thesis focused on transcription factor-targeted therapeutics.

  • Led scientific direction and investor engagement.

Nov 2022 - Jun 2024
1 year 8 months

Co-founder and Head of Platform Technology

Tesseract Medicines

  • Led medicinal chemistry and platform strategy for a novel covalent modality; advanced first asset to in vivo proof-of-concept.

  • Played key leadership role in shaping scientific narrative for fundraising efforts totaling $20M (Curie.Bio, Gordian Ventures).

Jul 2022 - Nov 2022
5 months

Entrepreneur-in-Residence

Gordian Ventures

  • Conducted scientific diligence and strategic planning for biotech newco formation.
Jul 2020 - Jul 2022
2 years 1 month

Principal Scientist - Medicinal Chemistry

Triana Biomedicines

  • Founding team member responsible for chemistry activities related to initial screening, platform development, and lead program optimization through to $110 mil Series A raise.
Oct 2018 - Jul 2020
1 year 10 months

Investigator II - Medicinal Chemistry

H3 Biomedicine

  • Initiated and led small-molecule degrader program.

  • Supported lead optimization for epigenetic and ADC programs in oncology.

Aug 2016 - Oct 2018
2 years 3 months

Investigator - Medicinal Chemistry

GlaxoSmithKline

  • Hit-to-lead and lead optimization for target classes within immuno-inflammation.

  • Member of team to nominate development candidate for RORY inverse agonist.

Mar 2014 - Aug 2016
2 years 6 months

Investigator - Process Chemistry

GlaxoSmithKline

  • Developed manufacturing route for the preparation of tapinarof scaled to over 100 kg.

Languages

English
Native

Education

Yale University

Ph.D. · Chemistry · United States

St. Lawrence University

B.S. · Chemistry · United States

Need a freelancer? Find your match in seconds.
Try FRATCH GPT
More actions